Baillie Gifford & Co
GHDX

Baillie Gifford & Co’s Genomic Health, Inc. GHDX Stock Holding History

Baillie Gifford & Co’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-548,376
Closed -$15.9M – 202
2016
Q3 		$15.9M Sell
548,376
-571,920
-51% -$15.9M 0.02% 130
2016
Q2 		$29M Sell
1,120,296
-216,793
-16% -$5.76M 0.05% 101
2016
Q1 		$33.1M Sell
1,337,089
-92,120
-6% -$2.53M 0.06% 100
2015
Q4 		$50.3M Hold
1,429,209
– – 0.09% 88
2015
Q3 		$30.2M Sell
1,429,209
-141,159
-9% -$3.64M 0.06% 105
2015
Q2 		$43.6M Sell
1,570,368
-318,258
-17% -$8.98M 0.08% 98
2015
Q1 		$57.7M Buy
1,888,626
+40,579
+2% +$1.29M 0.11% 94
2014
Q4 		$59.1M Sell
1,848,047
-16,159
-0.9% -$526K 0.12% 90
2014
Q3 		$52.8M Buy
1,864,206
+470,098
+34% +$13.1M 0.12% 89
2014
Q2 		$38.2M Buy
1,394,108
+56,393
+4% +$1.5M 0.08% 102
2014
Q1 		$35.2M Buy
1,337,715
+184,686
+16% +$5.3M 0.08% 96
2013
Q4 		$33.8M Buy
1,153,029
+317,463
+38% +$10.1M 0.08% 103
2013
Q3 		$25.6M Buy
835,566
+299,656
+56% +$10M 0.06% 107
2013
Q2 		$17M Buy
+535,910
New +$17.6M 0.05% 116

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Baillie Gifford & Co's GHDX Position: Q4 2016 in Review

Baillie Gifford & Co sold out of Genomic Health, Inc. (GHDX) in Q4 2016, closing a stake of 548,376 shares — an estimated $15.9M sold.

Baillie Gifford & Co first reported a position in GHDX in Q2 2013 and held it in 14 quarters. The position peaked at $59.1M in Q4 2014. 133 funds tracked by Wall St. Rank hold GHDX as of Q4 2016.

  • Baillie Gifford & Co reported no remaining Genomic Health, Inc. position as of Q4 2016 after selling out during the quarter.
  • Baillie Gifford & Co sold 548,376 Genomic Health, Inc. shares in Q4 2016, an estimated $15.9M.
  • Baillie Gifford & Co first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 14 quarters.
  • Baillie Gifford & Co's Genomic Health, Inc. position peaked at $59.1M in Q4 2014.
  • 133 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2016.

Based on Baillie Gifford & Co's 13F filing for Q4 2016, filed 14 Feb 2017.